Stepan (NYSE:SCL) Posts Quarterly Earnings Results, Misses Estimates By $0.33 EPS

Stepan (NYSE:SCLGet Free Report) announced its earnings results on Wednesday. The basic materials company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.33), Zacks reports. The business had revenue of $525.60 million for the quarter, compared to the consensus estimate of $520.97 million. Stepan had a net margin of 2.10% and a return on equity of 4.56%. Stepan’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.33 EPS.

Stepan Stock Up 0.3 %

SCL opened at $62.66 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $1.41 billion, a PE ratio of 31.17 and a beta of 0.84. Stepan has a 1-year low of $59.55 and a 1-year high of $94.76. The firm’s 50 day simple moving average is $64.41 and its two-hundred day simple moving average is $71.44.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Stepan from a “hold” rating to a “buy” rating in a research note on Friday, February 7th.

Read Our Latest Analysis on SCL

Stepan Company Profile

(Get Free Report)

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients.

Featured Articles

Earnings History for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.